Global and United States GP Vaccination Market Report & Forecast 2022-2028

Table of Contents

1 Study Coverage

• 1.1 GP Vaccination Product Introduction
• 1.2 Global GP Vaccination Outlook 2017 VS 2022 VS 2028
  • 1.2.1 Global GP Vaccination Sales in US$ Million for the Year 2017-2028
  • 1.2.2 Global GP Vaccination Sales in Volume for the Year 2017-2028
• 1.3 United States GP Vaccination Outlook 2017 VS 2022 VS 2028
  • 1.3.1 United States GP Vaccination Sales in US$ Million for the Year 2017-2028
  • 1.3.2 United States GP Vaccination Sales in Volume for the Year 2017-2028
• 1.4 GP Vaccination Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.4.1 The Market Share of United States GP Vaccination in Global, 2017 VS 2022 VS 2028
  • 1.4.2 The Growth Rate of GP Vaccination Market Size, United States VS Global, 2017 VS 2022 VS 2028
• 1.5 GP Vaccination Market Dynamics
  • 1.5.1 GP Vaccination Industry Trends
  • 1.5.2 GP Vaccination Market Drivers
  • 1.5.3 GP Vaccination Market Challenges
  • 1.5.4 GP Vaccination Market Restraints
• 1.6 Study Objectives
• 1.7 Years Considered

2 Market by Type

• 2.1 GP Vaccination Market Segment by Type
  • 2.1.1 DNA
  • 2.1.2 Non-replicating Viral Vector
  • 2.1.3 Protein Subunit
  • 2.1.4 RNA
  • 2.1.5 Others
• 2.2 Global GP Vaccination Market Size by Type
  • 2.2.1 Global GP Vaccination Sales in Value, by Type (2017, 2022 & 2028)
  • 2.2.2 Global GP Vaccination Sales in Volume, by Type (2017, 2022 & 2028)
  • 2.2.3 Global GP Vaccination Average Selling Price (ASP) by Type (2017, 2022 & 2028)
• 2.3 United States GP Vaccination Market Size by Type
  • 2.3.1 United States GP Vaccination Sales in Value, by Type (2017, 2022 & 2028)
  • 2.3.2 United States GP Vaccination Sales in Volume, by Type (2017, 2022 & 2028)
  • 2.3.3 United States GP Vaccination Average Selling Price (ASP) by Type (2017, 2022 & 2028)

3 Market by Application

• 3.1 GP Vaccination Market Segment by Application
  • 3.1.1 Adults
  • 3.1.2 Children
• 3.2 Global GP Vaccination Market Size by Application
  • 3.2.1 Global GP Vaccination Sales in Value, by Application (2017, 2022 & 2028)
  • 3.2.2 Global GP Vaccination Sales in Volume, by Application (2017, 2022 & 2028)
  • 3.3.3 Global GP Vaccination Average Selling Price (ASP) by Application (2017, 2022 & 2028)
• 3.3 United States GP Vaccination Market Size by Application
  • 3.3.1 United States GP Vaccination Sales in Value, by Application (2017, 2022 & 2028)
  • 3.3.2 United States GP Vaccination Sales in Volume, by Application (2017, 2022 & 2028)
  • 3.3.3 United States GP Vaccination Average Selling Price (ASP) by Application (2017, 2022 & 2028)

4 Global GP Vaccination Competitor Landscape by Company

• 4.1 Global GP Vaccination Market Size by Company
  • 4.1.1 Top Global GP Vaccination Manufacturers Ranked by Revenue (2021)
  • 4.1.2 Global GP Vaccination Revenue by Manufacturer (2017-2022)
  • 4.1.3 Global GP Vaccination Sales by Manufacturer (2017-2022)
  • 4.1.4 Global GP Vaccination Price by Manufacturer (2017-2022)
• 4.2 Global GP Vaccination Concentration Ratio (CR)
  • 4.2.1 GP Vaccination Market Concentration Ratio (CR) (2017-2022)
  • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of GP Vaccination in 2021
  • 4.2.3 Global GP Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.3 Global GP Vaccination Manufacturing Base Distribution, Product Type
  • 4.3.1 Global GP Vaccination Manufacturers, Headquarters and Distribution of Producing Region
  • 4.3.2 Manufacturers GP Vaccination Product Type
  • 4.3.3 Date of International Manufacturers Enter into GP Vaccination Market
• 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
• 4.5 United States GP Vaccination Market Size by Company
  • 4.5.1 Top GP Vaccination Players in United States, Ranked by Revenue (2021)
  • 4.5.2 United States GP Vaccination Revenue by Players (2020, 2021 & 2022)
  • 4.5.3 United States GP Vaccination Sales by Players (2020, 2021 & 2022)

5 Global GP Vaccination Market Size by Region

• 5.1 Global GP Vaccination Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global GP Vaccination Market Size in Volume by Region (2017-2028)
  • 5.2.1 Global GP Vaccination Sales in Volume by Region: 2017-2022
  • 5.2.2 Global GP Vaccination Sales in Volume Forecast by Region (2023-2028)
• 5.3 Global GP Vaccination Market Size in Value by Region (2017-2028)
  • 5.3.1 Global GP Vaccination Sales in Value by Region: 2017-2022
  • 5.3.2 Global GP Vaccination Sales in Value by Region: 2023-2028

6 Segment in Region Level & Country Level

• 6.1 North America
  • 6.1.1 North America GP Vaccination Market Size YoY Growth 2017-2028
  • 6.1.2 North America GP Vaccination Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.1.3 United States
  • 6.1.4 Canada
• 6.2 Asia-Pacific
  • 6.2.1 Asia-Pacific GP Vaccination Market Size YoY Growth 2017-2028
  • 6.2.2 Asia-Pacific GP Vaccination Market Facts & Figures by Region (2017, 2022 & 2028)
  • 6.2.3 China
  • 6.2.4 Japan
  • 6.2.5 South Korea
  • 6.2.6 India
  • 6.2.7 Australia
  • 6.2.8 China Taiwan
  • 6.2.9 Indonesia
  • 6.2.10 Thailand
  • 6.2.11 Malaysia
• 6.3 Europe
  • 6.3.1 Europe GP Vaccination Market Size YoY Growth 2017-2028
  • 6.3.2 Europe GP Vaccination Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.3.3 Germany
  • 6.3.4 France
  • 6.3.5 U.K.
  • 6.3.6 Italy
  • 6.3.7 Russia
• 6.4 Latin America
  • 6.4.1 Latin America GP Vaccination Market Size YoY Growth 2017-2028
  • 6.4.2 Latin America GP Vaccination Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.4.3 Mexico
  • 6.4.4 Brazil
  • 6.4.5 Argentina
• 6.5 Middle East and Africa
  • 6.5.1 Middle East and Africa GP Vaccination Market Size YoY Growth 2017-2028
  • 6.5.2 Middle East and Africa GP Vaccination Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.5.3 Turkey
  • 6.5.4 Saudi Arabia
  • 6.5.5 UAE

7 Company Profiles

• 7.1 Moderna
  • 7.1.1 Moderna Corporation Information
  • 7.1.2 Moderna Description and Business Overview
  • 7.1.3 Moderna GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 7.1.4 Moderna GP Vaccination Products Offered
  • 7.1.5 Moderna Recent Development
• 7.2 CanSino Biologicals
  • 7.2.1 CanSino Biologicals Corporation Information
  • 7.2.2 CanSino Biologicals Description and Business Overview
  • 7.2.3 CanSino Biologicals GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 7.2.4 CanSino Biologicals GP Vaccination Products Offered
  • 7.2.5 CanSino Biologicals Recent Development
• 7.3 Inovio Pharmaceuticals
  • 7.3.1 Inovio Pharmaceuticals Corporation Information
  • 7.3.2 Inovio Pharmaceuticals Description and Business Overview
  • 7.3.3 Inovio Pharmaceuticals GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 7.3.4 Inovio Pharmaceuticals GP Vaccination Products Offered
  • 7.3.5 Inovio Pharmaceuticals Recent Development
• 7.4 Shenzhen Geno-Immune Medical Institute
  • 7.4.1 Shenzhen Geno-Immune Medical Institute Corporation Information
  • 7.4.2 Shenzhen Geno-Immune Medical Institute Description and Business Overview
  • 7.4.3 Shenzhen Geno-Immune Medical Institute GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 7.4.4 Shenzhen Geno-Immune Medical Institute GP Vaccination Products Offered
  • 7.4.5 Shenzhen Geno-Immune Medical Institute Recent Development
• 7.5 GlaxoSmithKine
  • 7.5.1 GlaxoSmithKine Corporation Information
  • 7.5.2 GlaxoSmithKine Description and Business Overview
  • 7.5.3 GlaxoSmithKine GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 7.5.4 GlaxoSmithKine GP Vaccination Products Offered
  • 7.5.5 GlaxoSmithKine Recent Development
• 7.6 Pfizer
  • 7.6.1 Pfizer Corporation Information
  • 7.6.2 Pfizer Description and Business Overview
  • 7.6.3 Pfizer GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 7.6.4 Pfizer GP Vaccination Products Offered
  • 7.6.5 Pfizer Recent Development
• 7.7 Johnson＆Johnson
  • 7.7.1 Johnson＆Johnson Corporation Information
  • 7.7.2 Johnson＆Johnson Description and Business Overview
  • 7.7.3 Johnson＆Johnson GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 7.7.4 Johnson＆Johnson GP Vaccination Products Offered
  • 7.7.5 Johnson＆Johnson Recent Development
• 7.8 Heat Biologics
  • 7.8.1 Heat Biologics Corporation Information
  • 7.8.2 Heat Biologics Description and Business Overview
  • 7.8.3 Heat Biologics GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 7.8.4 Heat Biologics GP Vaccination Products Offered
  • 7.8.5 Heat Biologics Recent Development
• 7.9 Sanofi
  • 7.9.1 Sanofi Corporation Information
  • 7.9.2 Sanofi Description and Business Overview
  • 7.9.3 Sanofi GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 7.9.4 Sanofi GP Vaccination Products Offered
  • 7.9.5 Sanofi Recent Development
• 7.10 Takis Biotech
  • 7.10.1 Takis Biotech Corporation Information
  • 7.10.2 Takis Biotech Description and Business Overview
  • 7.10.3 Takis Biotech GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 7.10.4 Takis Biotech GP Vaccination Products Offered
  • 7.10.5 Takis Biotech Recent Development
• 7.11 Zydus Cadila
  • 7.11.1 Zydus Cadila Corporation Information
  • 7.11.2 Zydus Cadila Description and Business Overview
  • 7.11.3 Zydus Cadila GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 7.11.4 Zydus Cadila GP Vaccination Products Offered
  • 7.11.5 Zydus Cadila Recent Development
• 7.12 Codagenix
  • 7.12.1 Codagenix Corporation Information
  • 7.12.2 Codagenix Description and Business Overview
  • 7.12.3 Codagenix GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 7.12.4 Codagenix Products Offered
  • 7.12.5 Codagenix Recent Development
• 7.13 GeoVax
  • 7.13.1 GeoVax Corporation Information
  • 7.13.2 GeoVax Description and Business Overview
  • 7.13.3 GeoVax GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 7.13.4 GeoVax Products Offered
  • 7.13.5 GeoVax Recent Development
• 7.14 Bravovax
  • 7.14.1 Bravovax Corporation Information
  • 7.14.2 Bravovax Description and Business Overview
  • 7.14.3 Bravovax GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 7.14.4 Bravovax Products Offered
  • 7.14.5 Bravovax Recent Development
• 7.15 Altimmune
  • 7.15.1 Altimmune Corporation Information
  • 7.15.2 Altimmune Description and Business Overview
  • 7.15.3 Altimmune GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 7.15.4 Altimmune Products Offered
  • 7.15.5 Altimmune Recent Development
• 7.16 Vaxart
  • 7.16.1 Vaxart Corporation Information
  • 7.16.2 Vaxart Description and Business Overview
  • 7.16.3 Vaxart GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 7.16.4 Vaxart Products Offered
  • 7.16.5 Vaxart Recent Development
• 7.17 Clover Biopharmaceuticals
  • 7.17.1 Clover Biopharmaceuticals Corporation Information
  • 7.17.2 Clover Biopharmaceuticals Description and Business Overview
  • 7.17.3 Clover Biopharmaceuticals GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 7.17.4 Clover Biopharmaceuticals Products Offered
  • 7.17.5 Clover Biopharmaceuticals Recent Development
• 7.18 ImmunoPrecise
  • 7.18.1 ImmunoPrecise Corporation Information
  • 7.18.2 ImmunoPrecise Description and Business Overview
  • 7.18.3 ImmunoPrecise GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
  • 7.18.4 ImmunoPrecise Products Offered
  • 7.18.5 ImmunoPrecise Recent Development

8 Industry Chain and Sales Channels Analysis

• 8.1 GP Vaccination Industry Chain Analysis
• 8.2 GP Vaccination Key Raw Materials
  • 8.2.1 Key Raw Materials
  • 8.2.2 GP Vaccination Distributors
• 8.3 GP Vaccination Production Mode & Process
• 8.4 GP Vaccination Sales and Marketing
  • 8.4.1 GP Vaccination Sales Channels
  • 8.4.2 GP Vaccination Distributors
• 8.5 GP Vaccination Customers

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
  • 10.1.2 Data Source
• 10.2 Author Details